Novo Nordisk A/S
Eli Lilly’s weight loss drugs trounce sky-high expectations, boosting the stock
Eli Lilly bested investors’ super-high expectations at the American Diabetes Association conference this week, cementing its leadership in metabolic medicine and prompting Wall Street analysts to take another look at their sales forecasts. Across the board, analysts said the news is likely to lend support Lillto y shares, which have already popped more than 26% […]
Read More
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday. […]
Read More
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
Novo Nordisk said that it was cutting the supply of some doses of its popular obesity drug in the U.S. as it struggles to keep up with surging demand. Liselotte Sabroe | Afp | Getty Images Novo Nordisk‘s high-dose experimental obesity pill helped overweight or obese adults lose around 15% of their body weight, according […]
Read More
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Monday said it would stop developing its experimental obesity and diabetes pill, lotiglipron, due to elevated liver enzymes in patients who took the drug once a day in mid-stage clinical studies. Those elevated enzymes often indicate damage to cells in the liver, but the pharmaceutical giant […]
Read More
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images Novo Nordisk on Tuesday sued five medical spas and wellness clinics for allegedly selling cheaper, unauthorized versions of the company’s weight loss drugs Ozempic and Wegovy. The […]
Read More
This veteran investor’s funds have been outperforming because 2006. Listed here are his best investing recommendations
Less costly, quicker-rising, and of a higher quality than the rest of the industry. Those people are the qualities that outperforming portfolio supervisor Jordan Cvetanovski has looked for in shares for the earlier approximately 20 years. And the final results have tested to be steady throughout the world-wide monetary disaster, the era of zero fascination […]
Read More
Credit Suisse sees Eli Lilly headed higher as Mounjaro users espouse weight loss drug on social media
You can’t deny the buzz. Credit Suisse analyst Trung Huynh has combed through social media and is impressed by the awareness — and demand — for GLP-1 medications such as Eli Lilly ‘s Mounjaro. “Although we caution posts may have responder bias, and comments are in the public domain and unconfirmed, nonetheless we have parsed […]
Read More
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Weight-loss drugs have become a hot topic as public heath authorities and pharmaceutical companies seek to find solutions to the growing global obesity epidemic. Florian Gaertner | Photothek | Getty Images An oral drug made by Pfizer causes a similar amount of weight loss as, and works quicker than, rival Novo Nordisk‘s blockbuster injection Ozempic, […]
Read More
Analysts say these 11 top rated-undertaking shares are set to soar even much more — supplying a single around 85% upside
The yr is nearing its halfway mark, and world shares have been undertaking substantially better than they experienced in unstable 2022. The S & P 500 is up around 7% in the 12 months to day, and the MSCI Earth index is up all over 8% in the exact period of time. Most notably, Japan’s […]
Read More
Citi names its major biotech and pharma stock picks, offering one approximately 90% upside
The health care sector outperformed in Europe, India and China previous thirty day period, according to Citi, which named its major picks around the globe. Europe’s pharma sector appears to be significantly robust, the financial institution mentioned in a May 4 take note, with European big caps observing consensus earnings updates in April and favourable […]
Read More